Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry

被引：0
|
作者：
M E Work
E M John
I L Andrulis
J A Knight
Y Liao
A M Mulligan
M C Southey
G G Giles
G S Dite
C Apicella
H Hibshoosh
J L Hopper
M B Terry
机构：
[1] Mailman School of Public Health,Department of Epidemiology
[2] Columbia University,Division of Epidemiology, Department of Health Research and Policy
[3] Cancer Prevention Institute of California,Department of Molecular Genetics
[4] and Stanford Cancer Institute,Division of Epidemiology
[5] Stanford University School of Medicine,Department of Laboratory Medicine and Pathobiology
[6] Samuel Lunenfeld Research Institute,Department of Pathology
[7] Mount Sinai Hospital,Department of Epidemiology and Institute of Health and Environment
[8] University of Toronto,undefined
[9] Dalla Lana School of Public Health,undefined
[10] University of Toronto,undefined
[11] Laboratory Medicine Program,undefined
[12] University Health Network,undefined
[13] University of Toronto,undefined
[14] The University of Melbourne,undefined
[15] Cancer Epidemiology Centre,undefined
[16] Cancer Council Victoria,undefined
[17] Centre for Molecular,undefined
[18] Environmental,undefined
[19] Genetic and Analytic Epidemiology,undefined
[20] University of Melbourne,undefined
[21] School of Public Health,undefined
[22] Herbert Irving Comprehensive Cancer Center,undefined
[23] Columbia University,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
breast cancer; epidemiology; breastfeeding; oral contraceptives;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1367 / 1377
页数：10
相关论文
共 50 条
  • [21] A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate
    Scandlyn, M. J.
    Stuart, E. C.
    Somers-Edgar, T. J.
    Menzies, A. R.
    Rosengren, R. J.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 99 (07) : 1056 - 1063
  • [22] A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate
    M J Scandlyn
    E C Stuart
    T J Somers-Edgar
    A R Menzies
    R J Rosengren
    [J]. British Journal of Cancer, 2008, 99 : 1056 - 1063
  • [23] The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact?
    Rhodes, A.
    Jasani, B.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (01) : 95 - 96
  • [24] Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
    Garcia, Ximena
    Elia, Andres
    Galizzi, Lucrecia
    May, Maria
    Spengler, Eunice
    Martinez Vazquez, Paula
    Burruchaga, Javier
    Gass, Hugo
    Lanari, Claudia
    Lamb, Caroline A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (01) : 257 - 263
  • [25] Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer
    Mehmeti, Meliha
    Allaoui, Roni
    Bergenfelz, Caroline
    Saal, Lao H.
    Ethier, Stephen P.
    Johansson, Martin E.
    Jirstrom, Karin
    Leandersson, Karin
    [J]. BREAST CANCER RESEARCH, 2015, 17
  • [26] Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
    Ximena García
    Andrés Elía
    Lucrecia Galizzi
    María May
    Eunice Spengler
    Paula Martínez Vázquez
    Javier Burruchaga
    Hugo Gass
    Claudia Lanari
    Caroline A. Lamb
    [J]. Breast Cancer Research and Treatment, 2020, 180 : 257 - 263
  • [27] Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer
    Meliha Mehmeti
    Roni Allaoui
    Caroline Bergenfelz
    Lao H. Saal
    Stephen P. Ethier
    Martin E. Johansson
    Karin Jirström
    Karin Leandersson
    [J]. Breast Cancer Research, 17
  • [28] The prevalence of estrogen receptor-negative breast cancer in Ethiopia
    Eva Johanna Kantelhardt
    Assefa Mathewos
    Abreha Aynalem
    Tigeneh Wondemagegnehu
    Ahmedin Jemal
    Martina Vetter
    Erdme Knauf
    Anne Reeler
    Solomon Bogale
    Christoph Thomssen
    Andreas Stang
    Tufa Gemechu
    Pietro Trocchi
    Bekuretsion Yonas
    [J]. BMC Cancer, 14
  • [29] Tamoxifen for patients with estrogen receptor-negative breast cancer
    Swain, SM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) : 93S - 97S
  • [30] Estrogen receptor-negative tumour and positive family history for breast cancer highly modify the risk of second contra-lateral breast cancer
    Rapiti, E.
    Benhamou, S.
    Fioretta, G.
    Verkooijen, H.
    Chappuis, P.
    Neyroud-Caspar, I.
    Castiglione, M.
    Vinh-Hung, V.
    Vlastos, G.
    Bouchardy, C.
    [J]. EJC SUPPLEMENTS, 2010, 8 (03): : 95 - 95
12345